Hindustan Bio Sciences Ltd vs Valiant Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Hindustan Bio Sciences Ltd is ₹ 9.06 as of 30 Apr 15:30 . The P/E Ratio of Hindustan Bio Sciences Ltd is 0 as of March 2023 .The P/E Ratio of Valiant Laboratories Ltd is 0 as of March 2023 . The Market Cap of Hindustan Bio Sciences Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Valiant Laboratories Ltd is ₹ 0 crore as of March 2023 . The revenue of Hindustan Bio Sciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Valiant Laboratories Ltd for the Dec '25 is ₹ 53.09 crore as compare to the Sep '25 revenue of ₹ 47.07 crore. This represent the growth of 12.79% The ebitda of Hindustan Bio Sciences Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Valiant Laboratories Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ 0.94 crore. This represent the decline of -127% The net profit of Hindustan Bio Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Valiant Laboratories Ltd changed from ₹ -0.51 crore to ₹ -7.06 crore over 7 quarters. This represents a CAGR of 348.88% The Dividend Payout of Hindustan Bio Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Valiant Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Hindustan Bio Sciences Ltd

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991.
The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors.
The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

About Valiant Laboratories Ltd

Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s.
Bharat Chemicals' through deed of partnership dated October 17, 1980.
The said Partnership Firm, M/s.
Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
The Company gradually, commenced manufacturing of Paracetamol by late 1982.

FAQs for the comparison of Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd

Which company has a larger market capitalization, Hindustan Bio Sciences Ltd or Valiant Laboratories Ltd?

Market cap of Hindustan Bio Sciences Ltd is 9 Cr while Market cap of Valiant Laboratories Ltd is 428 Cr

What are the key factors driving the stock performance of Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd?

The stock performance of Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd?

As of May 4, 2026, the Hindustan Bio Sciences Ltd stock price is INR ₹9.06. On the other hand, Valiant Laboratories Ltd stock price is INR ₹78.85.

How do dividend payouts of Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd compare?

To compare the dividend payouts of Hindustan Bio Sciences Ltd and Valiant Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.